Searching. Please wait…
1445
37
174
31303
4607
2680
362
410
Abstract: Human glial cell line-derived neurotrophic factor (hGDNF) is a very promising protein for the treatment of Parkinson's disease and other neurodegenerative disorders. The present work describes a quick and simple method to obtain a high amount of purified hGDNF using a mammalian cell-derived system. The method is based on the high expression level provided by a Semliki Forest virus vector and its ability to induce a strong shut-off of host-cell protein synthesis in mammalian cells. As a result, hGDNF is the only protein present in the supernatant and can be efficiently purified by a single chromatographic step. Using this system it was possible to eliminate other secreted proteins from the culture medium, like insulin-like growth factor-5, which are hard to remove using other hGDNF production methods. Purified hGDNF presents a complex glycosylation pattern typical of mammalian expression systems and is biologically active. This protocol could be extended to other secreted proteins and could be easily scaled up for industrial purposes.
Fuente: International Journal of Pharmaceutics, 2013, 440(1), 19-26
Publisher: Elsevier
Year of publication: 2013
No. of pages: 8
Publication type: Article
DOI: 10.1016/j.ijpharm.2012.04.071
ISSN: 0378-5173,1873-3476
Publication Url: https://doi.org/10.1016/j.ijpharm.2012.04.071
SCOPUS
Citations
Google Scholar
Metrics
Read publication
ANSORENA, EDUARDO
CASALES, ERKUDEN
ARANDA, ALEJANDRO
ESTHER TAMAYO REVUELTA
GARBAYO, ELISA
SMERDOU, CRISTIAN
BLANCO-PRIETO, MARIA J.
AYMERICH, MARIA S.
Back